Stock Fundamentals

Company Information

▼
Company Name
Compass Pathways Plc
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NASDAQ
ISIN: US20451W1018
CIK: 0001816590
CUSIP: 20451W101
Currency: USD
Full Time Employees: 166
Phone: 44 71 6676 6461
Website: https://compasspathways.com
Fiscal Year End: December
IPO Date: Sep 18, 2020
Description:

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Address:

33 Broadwick Street, London, United Kingdom, W1F 0DQ

Directors & Officers

▼
Name Title Year Born
Mr. Kabir Kumar Nath M.A., M.B.A. CEO & Director 1964
Ms. Teri Loxam M.B.A. CFO, Principal Financial Officer & Principal Accounting Officer 1973
Dr. Guy Goodwin Chief Medical Officer 1948
Dr. Greg Ryslik Ph.D. Chief Technology Officer NA
Mr. Stephen D. Schultz Senior Vice President of Investor Relations NA
Ms. Anne Benedict Chief People Officer NA
Mr. Lars Christian Wilde Senior Advisor 1986
Dr. Susan C. Stansfield Ph.D. Advisor NA
Dr. Michael Gold M.D., M.Sc. Chief Research & Development Officer 1961
Ms. Lori Englebert M.B.A. Chief Commercial Officer 1979

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
RTW INVESTMENTS, LLC 8.76M Dec 31, 2025 7.71% $0.61 0.57%
Deep Track Capital, LP 7.86M Sep 30, 2025 6.92% $1.26 -11.00%
GMT Capital Corp 2.84M Sep 30, 2025 2.51% $0.74 59.66%
Millennium Management LLC 2.72M Sep 30, 2025 2.39% $0.01 55.92%
TANG CAPITAL MANAGEMENT LLC 2.20M Sep 30, 2025 1.94% $0.49 69.23%
UBS Group AG 2.14M Sep 30, 2025 1.89% $0.00 27.75%
ARK Investment Management LLC 2.12M Sep 30, 2025 1.87% $0.07 28.61%
Partner Fund Management LP 1.66M Sep 30, 2025 1.46% $0.73 -6.54%
Two Sigma Investments LLC 1.64M Dec 31, 2025 1.45% $0.02 52.91%
Eagle Health Investments LP 1.52M Dec 31, 2025 1.34% $2.30 62.42%
D. E. Shaw & Co LP 1.45M Dec 31, 2025 1.28% $0.01 114.19%
Jefferies Financial Group Inc 1.38M Sep 30, 2025 1.21% $0.04 0.00%
HSBC Holdings PLC 1.26M Sep 30, 2025 1.11% $0.00 16.70%
Ameriprise Financial Inc 1.21M Sep 30, 2025 1.06% $0.00 0.00%
Aisling Capital Management LP 1.20M Dec 31, 2025 1.06% $1.73 0.00%
Morgan Stanley - Brokerage Accounts 1.03M Sep 30, 2025 0.91% $0.00 287.58%
Ally Bridge Group (NY) LLC 1.03M Sep 30, 2025 0.90% $3.58 -30.88%
The Toronto-Dominion Bank 1.00M Sep 30, 2025 0.88% $0.01 100.00%
Siren, L.L.C. 1.00M Dec 31, 2025 0.88% $0.21 0.00%
Renaissance Technologies Corp 967.85K Dec 31, 2025 0.85% $0.01 1.75%

Shares Statistics

▼
Shares Outstanding: 113.52M
Shares Float: 73.40M
% Insiders: 935.50%
% Institutions: 5,298.30%
Short % Float: 5.80%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 RTW INVESTMENTS, LLC 8.76M 7.71% ▲ 0.57% Dec 31, 2025
2 Deep Track Capital, LP 7.86M 6.92% ▼ 11.00% Sep 30, 2025
3 GMT Capital Corp 2.84M 2.51% ▲ 59.66% Sep 30, 2025
4 Millennium Management LLC 2.72M 2.39% ▲ 55.92% Sep 30, 2025
5 TANG CAPITAL MANAGEMENT LLC 2.20M 1.94% ▲ 69.23% Sep 30, 2025
6 UBS Group AG 2.14M 1.89% ▲ 27.75% Sep 30, 2025
7 ARK Investment Management LLC 2.12M 1.87% ▲ 28.61% Sep 30, 2025
8 Partner Fund Management LP 1.66M 1.46% ▼ 6.54% Sep 30, 2025
9 Two Sigma Investments LLC 1.64M 1.45% ▲ 52.91% Dec 31, 2025
10 Eagle Health Investments LP 1.52M 1.34% ▲ 62.42% Dec 31, 2025

Valuation Metrics

▼
Enterprise Value: $632.51M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $783.27M
EBITDA: $-154.38M
Book Value: $0.39
Earnings/Share: $-2.72
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.43%
ROE (TTM): -205.81%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 5.92x 0.21x 0.28x -39.79x -0.21x
2023-12-31 13.33x 0.14x 0.18x -62.12x -0.27x
2022-12-31 12.29x 0.01x 0.08x -18.30x -0.02x
2021-12-31 19.55x 0.01x 0.05x -19.84x -0.03x
2020-12-31 29.36x 0.00x 0.03x -2.09x 0.00x
2019-12-31 1.35x 2.48x 0.74x -18.46x -0.95x
2018-12-31 14.24x 0.00x 1.54x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 26, 2024 Life Sciences N.V. Atai N/A Sale 2.66M $6.05 $16.09M
May 02, 2024 George Jay Goldsmith N/A Sale 9.62K $8.29 $79.76K
Apr 16, 2024 George Jay Goldsmith N/A Sale 23.88K $8.53 $203.70K
Apr 01, 2024 George Jay Goldsmith N/A Sale 25.75K $8.96 $230.72K
Mar 28, 2024 Ekaterina Malievskaia N/A Sale 25.75K $8.65 $222.74K
Mar 12, 2024 George Jay Goldsmith N/A Sale 15.74K $10.58 $166.53K
Feb 26, 2024 Ekaterina Malievskaia N/A Sale 17.77K $10.45 $185.64K
Feb 23, 2024 Ekaterina Malievskaia N/A Sale 11.86K $10.06 $119.33K
Feb 06, 2024 Ekaterina Malievskaia N/A Sale 19.85K $10.59 $210.24K
Jan 22, 2024 George Jay Goldsmith N/A Sale 25.75K $8.35 $215.01K
Jan 19, 2024 George Jay Goldsmith N/A Sale 20.21K $7.99 $161.44K
Dec 13, 2023 Ekaterina Malievskaia N/A Sale 2.86K $7.82 $22.33K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CMPS.US!